Stargardt disease and progress in therapeutic strategies
Background Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
[PDF][PDF] Stargardt disease and progress in therapeutic strategies
D Huang, RCH Jeffery, MT Aung-Htut, S McLenachan… - 2021 - researchgate.net
ABSTRACT Background: Stargardt disease (STGD1) is an autosomal recessive retinal
dystrophy due to mutations in ABCA4, characterized by subretinal deposition of lipofuscin …
dystrophy due to mutations in ABCA4, characterized by subretinal deposition of lipofuscin …
Stargardt disease and progress in therapeutic strategies
D Huang, RCH Jeffery, MT Aung-Htut… - Ophthalmic …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
Stargardt disease and progress in therapeutic strategies
D Huang, RCH Jeffery… - Ophthalmic …, 2022 - research-repository.uwa.edu.au
Background: Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
Stargardt disease and progress in therapeutic strategies.
D Huang, HJ RC, MT Aung-Htut… - Ophthalmic …, 2021 - europepmc.org
Background Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
[PDF][PDF] Stargardt disease and progress in therapeutic strategies
D Huang, RC Heath Jeffery, MT Aung-Htut - 2021 - researchportal.murdoch.edu.au
ABSTRACT Background: Stargardt disease (STGD1) is an autosomal recessive retinal
dystrophy due to mutations in ABCA4, characterized by subretinal deposition of lipofuscin …
dystrophy due to mutations in ABCA4, characterized by subretinal deposition of lipofuscin …
Stargardt disease and progress in therapeutic strategies
D Huang, RCH Jeffery… - Ophthalmic …, 2021 - researchportal.murdoch.edu.au
Background: Stargardt disease (STGD1) is an autosomal recessive retinal dystrophy due to
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …
mutations in ABCA4, characterized by subretinal deposition of lipofuscin-like substances …